DENTSPLY SIRONA Inc. (XRAY) Position Cut by Reliance Trust Co. of Delaware

Reliance Trust Co. of Delaware reduced its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,919 shares of the medical instruments supplier’s stock after selling 155 shares during the period. Reliance Trust Co. of Delaware’s holdings in DENTSPLY SIRONA were worth $644,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of XRAY. TNB Financial bought a new position in DENTSPLY SIRONA during the first quarter worth approximately $259,000. First National Bank of Omaha raised its position in DENTSPLY SIRONA by 1.6% in the first quarter. First National Bank of Omaha now owns 144,523 shares of the medical instruments supplier’s stock worth $9,024,000 after buying an additional 2,318 shares during the last quarter. National Pension Service raised its position in DENTSPLY SIRONA by 37,487.7% in the first quarter. National Pension Service now owns 201,846 shares of the medical instruments supplier’s stock worth $12,646,000 after buying an additional 201,309 shares during the last quarter. Gulf International Bank UK Ltd raised its position in DENTSPLY SIRONA by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 74,565 shares of the medical instruments supplier’s stock worth $4,655,000 after buying an additional 1,000 shares during the last quarter. Finally, Creative Planning raised its position in DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock worth $425,000 after buying an additional 70 shares during the last quarter. 95.13% of the stock is owned by hedge funds and other institutional investors.

Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 52.85 on Friday. DENTSPLY SIRONA Inc. has a 52-week low of $52.73 and a 52-week high of $65.68. The stock’s market cap is $12.13 billion. The firm’s 50-day moving average price is $61.35 and its 200-day moving average price is $62.19.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. During the same period in the prior year, the company posted $0.76 EPS. The firm’s revenue for the quarter was down 2.9% on a year-over-year basis. Equities analysts predict that DENTSPLY SIRONA Inc. will post $2.69 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -10.09%.

ILLEGAL ACTIVITY WARNING: “DENTSPLY SIRONA Inc. (XRAY) Position Cut by Reliance Trust Co. of Delaware” was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.com-unik.info/2017/08/19/dentsply-sirona-inc-xray-shares-sold-by-reliance-trust-co-of-delaware-updated-updated.html.

A number of research firms have recently commented on XRAY. BidaskClub lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target for the company in a report on Thursday, July 13th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $75.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. HC Wainwright started coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target for the company. Finally, Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $66.25.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit